Knowledge and Practice of Physicians towards the use of Influenza Vaccine in Chronic Obstructive Pulmonary Disease in UAE
Main Article Content
Keywords
Chronic Obstructive Pulmonary Disease (COPD), Influenza vaccine, Exacerbations, Physicians
Abstract
Introduction: Chronic obstructive pulmonary disease (COPD) is an inflammation in airway that limits airflow to lungs. According to the GOLD guidelines based on the severity of airflow obstruction, it classified as mild, moderate, severe, and very severe. People at higher risk of developing flu complications like COPD patients. Flu vaccine was one of treatment to reduce severe exacerbation of COPD. Studies were conducted to express physicians’ knowledge, attitude, and practices used to reduce the severity of COPD exacerbations. No studies have been conducted in UAE. This study will increase the awareness of recommending influenza vaccine in COPD patients by physicians. Aim: To determine the knowledge and practice of healthcare providers regarding the use of influenza (flu) vaccine in patients having COPD with severe exacerbations in UAE. Methods: An anonymous cross-sectional online survey was conducted in two hospitals, thirteen primary healthcare centers, and one preventive medicine center in the northern area of the UAE. The study covered 200 physicians. SPSS statistical software version 27 was used to analyze the data. Results: The study showed that 95.5% of physicians agreed there was a relationship between influenza infection and the severity of exacerbation in COPD patients (p-value=0.00). Around 70% of the physicians prescribe flu vaccines to COPD patients with severe exacerbation (P-value=0.00) and 61% of physicians reported that COPD patients do take the influenza vaccine annually (P-value=0.00). Many factors greatly impacted the practitioner’s practices in recommending influenza vaccine to COPD patients. 79% of physicians considered patients risk for respiratory failure and severe exacerbations, following the GOLD guideline and information from experts (72% and 61% respectively) and reduction in the cost and burden of hospitalization (77.5%) directed them to prescribe influenza vaccine. Conclusion: This research is considered the first study conducted in Northern region of UAE regarding the use of influenza vaccine in COPD patients. The physicians agreed on the importance of prescribing influenza vaccines to COPD patients. Still, they recommended that policies should be established (following the GOLD guidelines) to mandate the use of influenza vaccine in COPD patients with severe exacerbations.
References
2. Kopsaftis Z, Wood-Baker R, Poole P. Influenza vaccine for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev. 2018 Jun 26;6(6):CD002733. doi: 10.1002/14651858.CD002733.pub3
3. Trappenburg, J. C. A., van Deventer, A. C., Troosters, T., Verheij, T. J. M., Schrijvers, A. J. P., Lammers, J.-W. J., &Monninkhof, E. M. (2011). The impact of using different symptom- based exacerbation algorithms in patients with COPD. European Respiratory Journal, 37(5), 1260–1268.
4. Rodriguez, T. (2019, August 27). Managing Influenza as a Coinfection in COPD. Pulmonology Advisor.
5. Zhao, C. L., Huang, J. W. , Zhang, L. , Zhang, Q. R. , Li, Q. M. , & Zhou, M. (2018). Respiratory virus infections and inflammatory cytokines in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease. Chinese Journal of Tuberculosis and Respiratory Diseases, 942–948.
6. Fu C, He Q, Li Z, Xu J, Li Y, Lu J, et al. Seasonal influenza vaccine effectiveness among children, 2010–2012. Influenza Other Respir Viruses. (2013) 7:1168–74. doi: 10.1111/irv.12157
7. Dawood F, Chung J, Kim S, Zimmerman R, Nowalk M, Jackson M, et al. Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness-United States, February 2020. MMWMorbid R Mortality Wkly Rep. (2020) 69:177. doi: 10.15585/mmwr.mm6907a1
8. Balasubramani GK, Nowalk MP, Sax TM, Suyama J, Bobyock E, Rinaldo CR Jr, et al. Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011–2016. Influenza Other Respir Viruses. (2020) 14:380–90. doi: 10.1111/irv.12741
9. Arriola C, Garg S, Anderson EJ, Ryan PA, George A, Zansky SM, et al. Influenza vaccination modifies disease severity among community-dwelling adults hospitalized with influenza. Clin Infect Dis. (2017) 65:1289. doi: 10.1093/cid/cix468
10. Ferdinands J, Gaglani M, Martin E, Middleton D, Monto A, Murthy K, et al. Prevention of influenza hospitalization among adults in the United States, 2015–2016: results from the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). J Infect Dis. (2019) 220:1265. doi: 10.1093/infdis/jiy723
11. Nichol, K. L., & Zimmerman, R. (2001). Generalist and Subspecialist Physicians’ Knowledge, Attitudes, and Practices Regarding Influenza and Pneumococcal Vaccinations for Elderly and Other High-Risk Patients. Archives of Internal Medicine, 161(22), 2702.
12. Cheng, Y., Cao, X., Cao, Z., Xu, C., Sun, L., Gao, Y., Wang, Y., Li, S., Wu, C., Li, X., Wang, Y., &Leng, S. X. (2020). Effects of influenza vaccination on the risk of cardiovascular and respiratory diseases and all-cause mortality. Ageing Research Reviews, 62, 101124.
13. Taber, K. S. (2018). The Use of Cronbach’s Alpha When Developing and Reporting Research Instruments in Science Education. Research in Science Education, 48(6), 1273–1296.
14. Abu-Gharbieh E, Fahmy S, Rasool BA, Khan S. Influenza vaccination: healthcare workers attitude in three Middle East countries. Int J Med Sci. (2010) 7:319. doi: 10.7150/ijms.7.319
15. Romani M, Musharrafieh U, Lakkis N, Hamadeh G. Family physicians beliefs and attitudes regarding adult pneumococcal and influenza immunization in Lebanon. Fam Pract. (2011) 28:632.
16. Alshammari T, AlFehaid L, AlFraih J, Aljadhey H. Health care professionals’ awareness of, knowledge about and attitude to influenza vaccination. Vaccine. (2014) 32:5957. doi: 10.1016/j.vaccine.2014.08.061
17. Ahmed Wesam S., Abu Farha Rana, Halboup Abdulsalam M., Alshargabi Arwa, Al-mohamadi Ahmed, Abu-rish Eman Y., Zawiah Mohammed, Al-AshbatYousf K., Al-Jamei Sayida. (2023). Knowledge, attitudes, perceptions, and practice toward seasonal influenza and its vaccine: A cross-sectional study from a country of conflict. Frontiers in Public Health, 11.
18. Pelullo, C. P., della Polla, G., Napolitano, F., di Giuseppe, G., & Angelillo, I. F. (2020). Healthcare Workers’ Knowledge, Attitudes, and Practices about Vaccinations: A Cross-Sectional Study in Italy. Vaccines, 8(2), 148.
19. Abalkhail, Mohammed S., Mohannad S. Alzahrany, Khaled A. Alghamdi, Muath A. Alsoliman, Mosa A. Alzahrani, Badr S. Almosned, Ibrahim M. Gosadi, Shabana Tharkar. (2017). Uptake of influenza vaccination, awareness and its associated barriers among medical students of a University Hospital in Central Saudi Arabia. Journal of Infection and Public Health. 10(5): 644-648.
20. Bertoldo, G., Pesce, A., Pepe, A., Pelullo, C. P., & di Giuseppe, G. (2019). Seasonal influenza: Knowledge, attitude and vaccine uptake among adults with chronic conditions in Italy. PLOS ONE, 14(5), e0215978.
21. Glaab, T. (2012). Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany. International Journal of Chronic Obstructive Pulmonary Disease, 101.
22. Rutschmann, O. T., Janssens, J.-P., Vermeulen, B., & Sarasin, F. P. (2004). Knowledge of guidelines for the management of COPD: a survey of primary care physicians. Respiratory Medicine, 98(10), 932–937.
23. Hakim, SA, Amin, W, Allam, MF, Fathy, AM, Mohsen, A. Attitudes, beliefs and practice of Egyptian healthcare workers towards seasonal influenza vaccination. Influenza Other Respi Viruses. 2021; 15(6): 778-788.
24. Chen S, Jiang Y, Tang X, Gan L, Xiong Y, Chen T, et al. Research on knowledge, attitudes, and practices of influenza vaccination among healthcare workers in Chongqing, China-based on structural equation model. Front Public Health. (2022) 10:853041. doi: 10.3389/fpubh.2022.853041
